A look at why these two biopharma companies could have targets on their backs. Source: BioSpace

The portfolio consists of acute, chronic and oncology products. Source: BioSpace

The company believes the Translarna data is compelling and pointed to the success the drug is having in Europe. Source: BioSpace

Here's a look at the seven best life science companies to work for in 2018. Source: BioSpace

Hyalex Orthopaedics launched in May 2017 as a medical device company that intends to advance new products featuring HYALEX technology, a synthetic polymer that mimics cartilage. Source: BioSpace

Here is a look at key takeaways from presentations made by four major pharma and biotech stocks at the annual J.P. Morgan healthcare conference. Source: BioSpace

Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace

Investors and analysts, after all, had been speculating, even nagging, on who the company should buy for several years. Source: BioSpace

Bloomberg said Nestle had submitted the highest offer and Merck was likely to select a winner during the first quarter, but might also choose not to sell the assets after…

Moderna unleashed a torrent of updates yesterday. Source: BioSpace